Livazo 1 mg, 2 mg and 4 mg film-coated tablets
pitavastatin
Read this leaflet carefully before you start taking this medicine, because it contains important information for you.
Contents of theleaflet:
Livazo contains a substance called pitavastatina. It belongs to a group of medications called ‘statins’. Livazo is used to correct the levels of fatty substances (lipids)in the blood and it can be taken by both children aged 6 years and older and adults. An imbalance of fats, especially cholesterol, may sometimes cause a heart attack or a cerebral infarction.
You have been prescribed Livazo because you have an imbalance of fats, and changes in your diet and lifestyle have not been sufficient to correct it. You must continue with a low-cholesterol diet and lifestyle changes while taking Livazo.
Do not take Livazo:
Consult your doctor or pharmacist before starting to take Livazo if you are unsure.
Warnings and precautions:
Consult your doctor or pharmacist before starting to take Livazo if:
Consult your doctor or pharmacist if any of the above applies to you (or if you are unsure). Also inform your doctor or pharmacist if you experience persistent muscle weakness. Further tests and additional medicines may be necessary to diagnose and treat this problem.
While you are taking this medicine, your doctor will check if you have diabetes or are at risk of developing diabetes. This risk of diabetes increases if you have high levels of sugar and fat in your blood, being overweight and high blood pressure.
Children and adolescents:
Livazo should not be given to children under 6 years.
Before taking Livazo, adolescents should receive guidance and advice on contraceptives.
Other medicines and Livazo:
Inform your doctor or pharmacist if you are taking, have taken recently or may need to take any other medicine. Some medicines may make other medicines less effective.
Specifically, inform your doctor or pharmacist if you are taking any of the following medicines:
Consult your doctor or pharmacist if any of the above applies to you (or if you are unsure).
Taking Livazo with food and drink:
You can take Livazo with or without food.
Pregnancy, breastfeeding and fertility:
If you are pregnant or breastfeeding, or think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before using this medicine.
If you are a woman and may become pregnant, you must use an effective contraceptive method while taking Livazo.If you become pregnant while taking Livazo, stop taking Livazo and see your doctor immediately.
If you are pregnant or breastfeeding, consult your doctor or pharmacist before starting to take any medicine.
Driving and using machines:
Livazo is unlikely to affect your ability to drive or use machines. However, if you feel dizzy or drowsy while taking Livazo, do not drive or use machines or tools.
Livazo contains lactose:
Livazo contains lactose (a type of sugar). If your doctor has told you that you have a certain sugar intolerance, consult with them before taking this medicine.
Follow the medication administration instructions exactly as indicated by your doctor. If in doubt, consult your doctor or pharmacist again.
How to Take This Medication
Swallow the tablet whole with water, with or without food. You can take it at any time of the day. However, try to take the tablet at the same time every day.
How Much to Take
Use in Children
Other Things You Need to Know While Taking Livazo
If You Take Too Much Livazo
If you take more Livazo than you should, inform your doctor or go to the hospital immediately. Bring the medication packaging with you.
If You Forget to Take Livazo
Do not worry, take the next dose at the correct time. Do not take a double dose to make up for the missed dose.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.This medicine can cause the following side effects:
Stop taking Livazo and see your doctor immediately if you observe any of the following serious side effects, as you may need urgent medical treatment:
Other side effects include:
Frequent (affecting less than 1 in 10 people)
Rare (affecting less than 1 in 100 people)
Rare (affecting less than 1 in 1,000 people)
Unknown frequency (cannot be estimated from available data)
Other possible side effects
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the blister pack and on the box. The expiration date is the last day of the month indicated.
Do not store at a temperature above25°C. Store the blister pack in the outer packagingto protect it from light.
Medicines should not be disposed of through drains or inthe trash. Disposeof the containers and medicines that you no longer need at the SIGRE collection pointatthe pharmacy. Incase of doubt, ask your pharmacist how to dispose of the containers and medicines that you no longer need. By doing so, you will help protect the environment.
Composition of Livazo
The active ingredient ispitavastatina calcium, equivalent to 1mg, 2mg or 4mg of pitavastatina.
The other components are lactose monohydrate, LS-hydroxypropylcellulose, hypromellose (E464), titanium dioxide (E171), triethyl citrate (E1505), magnesium aluminometasilicate, magnesium stearate, and anhydrous colloidal silica.
Appearance of the product and contents of the packaging
Livazo film-coated tablets are presented in packaging of 7, 28, 30, 90 or 100.Only some sizes of packaging may be commercially available.
The tablets are round, white and have the letters ‘KC’ engraved on one side. To help identify the different concentrations, they are of different sizes and have ‘1’, ‘2’ or ‘4’ engraved on the other side.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization:
Kowa Pharmaceutical Europe GmbH.
Görreshof 151, 53347 Alfter
Germany
Responsible for manufacturing:
Pierre FabreMédicament Production*,
Rue du Lycée, 45502 Gien Cedex
France
Or
Recordati Industria Chimica e Farmaceutica S.p.A.*
Vía M. Civitali, 1, 20148 Milan
Italy
Local Representative:
Casen Recordati, S.L.
Autovía de Logroño, Km 13,300
50180 Utebo (Zaragoza)
Spain
Last review date of this leaflet: April 2023.
Other sources of information
The detailed information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.